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The health care-related infections are well-known in a critical care setting, but reports of those infections in solid
organ transplanted patients are scarce. We developed a study of retrospective cohort in a tertiary teaching hospital
for 14 months. Eighty-one patients underwent solid organ transplants. The global incidence of health care-related
infection was 42.0%. Fifteen percent of the cases were occurrences of surgical site infections, 14.0% pneumonias,
9.0% primary blood stream infections, 4.0% urinary tract infections and 2.0% skin infection. The most prevalent
etiologic agents were K. pneumoniae (8.6%), P. aeruginosa (7.4%); A. baumannii (5.0%) and S. aureus (2.5%).
Mortality was 18.0%, none of then related to health care infections. The high rate of those infections, mainly
surgical site infections, suggests a demand for stricter measures to prevent and control health care-related infections.
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Solid organ transplant became, in the last few decades, an
uncontested therapeutic option to several terminal diseases.
Advances on surgical techniques and immunosuppression
allowed the carrying out of over 24,000 transplants per year,
in the USA [1].
Several Brazilian medical centers perform solid organ
transplants with results similar to those found in the medical
literature, and the number of procedures has increased in the
last decade thanks to governmental policies [2].
Despite advances in immunosuppression, prophylaxis and
early diagnosis, incidence of infectious complications remain
high and they have been associated with loss of graft function
and increased mortality [3].
Health care-related infections have been reported as a
regular complication in severely ill recipients of solid organ
transplants, facilitated by the use of invasive procedures,
associated diseases and immunosuppression treatment.
Bacteremia and septic shock remain important causes of
mortality in solid organ recipients. In 2005, Candel et al.
communicated a series of 466 bacteremia episodes in 382
recipients and 66 episodes of septic shock (14.0%) after several
types of transplant recipients [4]. Singh et al. reported that
50.0% of all blood stream infections found in liver transplant
recipients occur in the first month after the procedure [5],
similar results were found by Rodriguez et al. among heart
transplanted patients [6].
Sénéchal et al. found 6.5% incidence of surgical site
infection after heart transplantation with a mortality rate of
6.7%. Staphylococcus species were cultured intraoperatively
from the majority of the patients [7].
Although many papers review the whole spectrum of
infections in solid organ transplant recipients, few specifically
emphasize the first days after the procedure and the infections
related to health care.
Material and Methods
Data in this study arose from a retrospective chart review
of 81 consecutive solid organs transplants (heart, liver, kidney
and double kidney and pancreas) performed between January
2004 and March 2005 at São Paulo Hospital, a 700-bed tertiary
teaching hospital.
The epidemiological surveillance of the health care-
related infections was performed by a specific appliance of
the National Nosocomial Surveillance System (NNISS)
methodology [5,8]. An infection control professional
diagnosed each infection according to standardized
diagnosis of the Center for Disease Control and Prevention
(CDC) criteria.
All infections diagnosed between the procedure and the
30-first days after the surgery have been included in this
review. Patients with infections are referred as a case. A control
group was obtained with transplanted patients without
diagnosis of infections.
Measures of significances were assessed by a univariate
analysis. Chi-square, Fischer’s exact test and Wilcoxon’s
test were used as appropriate. A multivariable analysis
(logistic regression) was performed when possible. A p
value < 0.05 was considered statistically significant for all
tests.
Results
During the period of study, were performed 35 double
kidney and pancreas transplants (43.2%), 20 heart
transplants (24.7%), 17 liver transplants (21.0%), and nine
kidney transplants (11.1%). As show in Table 2, cases and
controls were not different in respect to gender, age and
preoperative stay. The only difference found was an
expected higher surgical risk index (IRIC) score among cases
(p = 0.034).  Surgery length time in the different transplant
sites are shown in Table 1.
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The length of the pre-transplant period was longer in heart
transplant patients than in the patients of other transplant
sites (8.7 days; range 0-153 days) but the incidence of HCRI
was not different among them, even when the pre-transplant
period was longer than 30 days (p = 0.486) (Figure 1).
The mortality rate during the first 30 post-transplant days
was 18.6% in control group and 13.6% in case group (p =
0.151), none due to infection (Table 2).
Thirty four episodes of HCRI were diagnosed among 81
recipients (global incidence of 42.0%). The incidence rate by
patient of HCRI was 27.0% (34 HCRI episodes in 22 patients).
Table 3 shows the spread of the infections by transplant site.
Fifteen percent of the HCRI were surgical site infections,
14.0% pneumonias, 9.0% primary bloodstream infections, 4.0%
urinary tract infections and 2.0% skin infections. Surgical site
infection was more common in double kidney-pancreas
recipients (OR 10.5; IC 2.23-49.52; p = 0.05) and primary blood
stream infections among liver recipients (OR 6.79; IC 1.06-
43.36; p = 0.009).
The most prevalent etiologic agents were K.
pneumoniae (8.6%), P. aeruginosa (7.4%); A. baumannii
(5.0%) and S. aureus (2.5%). No significant pattern of
microorganism was identified among the different solid
organ recipients (Table 4).
Discussion
Despite the extensive literature about infectious
complications in solid organ transplants patients, there are
very few studies that emphasize on the health care-related
infections.
Regarding patients submitted to liver transplant, the
incidence of health care-related infections in our study, by
infection site, was similar to literature [9]. About the agents,
there was no incidence of Gram-positive bacteria, in
accordance to other reports [6].
Montoya et al. reported, in heart transplant, that main
bacterial infection sites were the lungs and urinary tract
[10]. In our study, however, the most observed episode of
Figure 1. Preoperative stay by solid organ transplant site (means and 95.0% confidence interval).
Table 1. Surgical procedures time
+ Chi-square.
Infections in Solid Organ Transplants
Surgical procedures time Heart Kidney Double kidney-pancreas Liver Total
< 5h 2 8 0 1 11
5h 7 0 6 0 13
6h 3 0 10 0 13
7h 1 0 11 0 12
8h 4 0 6 3 13
9h 1 0 0 4 5
> 10h 2 1 1 6 10
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Table 4. Microorganism spread by site of infection
HCRI was surgical site infection (20.0%), an incidence rate
higher than other studies, whose range varies from 3.5% to
6.5% [7,11].
Also, we found a long preoperative time in heart transplant
recipients. Similar to literature, our terminal heart failure patients
had a high rate of use of vasoactive drugs, mechanic
ventricular support and indwelling catheters [12].
Unexpectedly, preoperative time was not identified as an
infection risk factor.
In kidney and double kidney and pancreas transplantation,
a low incidence of urinary tract infection was found, which
was the most common infection complication related in the
literature [11,13]. However, in the double kidney and pancreas
transplantation we found, again, a high incidence of surgical
site infection.
The ASA index, the potential contamination of the
surgical incision, and the length of surgery may interfere
on the incidence of surgical site infections. These
variables are appraised separately and graded by the
surgical risk index. The higher the risk Index, the greater
the expected surgical site infection risk, as confirmed in
our study.
Patients submitted to solid organ transplant, in general,
have high ASA scores, due to comorbidities, and low potential
for contamination of the surgical incision, since most surgeries
are clean or only potentially contaminated.
Infections in Solid Organ Transplants
Table 2. Characteristics of cases and controls
Case Control p + OR CI
Total (%) 22 (27.1%) 59 (72.8%) - - -
Male (%) 11 (50%) 31 (52.5%) NS -
Age (y) 36.1 ± 12.5 * 36.9 ±12.7* NS -
Preoperative stay (%) 27.3% 40.7% NS -
Mean preoperative stay (d) 8.9 ± 26.4* 2.8 ± 16.1* NS -
IRIC (%) -
0 1 (20.0%) 4 (80.0%) NS
1 4 (12.9%) 27 (87.1%) 0.02 4.05 1.3-12.4
2 17 (39.5%) 26 (60.5%) 0.014 3.15 1.2-8.3
Mortality (%) 3 (13.6%) 11 (18.6%) NS
*Standard deviation; + Chi-square; NS=not significant; OR=odds ratio/CI confidence interval (95%).
Table 3. Infection spread by transplant site
Total
Heart Kidney
Double
Liver
p value Odds CI (95.0%)N=20 N=9
Kidney-
N=17 ratioPancreas
N=35
Surgical site 12 (15%) 4 (20%) 0 7 (20%) 1 (6%) 0.009 10.5 2.23-49.52
Pneumonia 11 (14%) 3 (15%) 0 1 (3%) 7 (41%) NS NS NS
Urinary tract 3 (4%) 0 1 (11%) 2 (6%) 0 NS NS NS
Primary bloodstream 7 (9%) 1 (5%) 0 1 (3%) 5 (29%) 0.05 6.79 1.06-43.36
Skin 1 (2%) 1 (5%) 0 0 0 NS NS NS
Total 34 9 (45%) 1 (11%) 11  (31%) 13 (76%) NS NS NS
* Standard deviation; + Chi-square; NS=not significant; OR=odds ratio; CI confidence interval (95%).
K. pneumoniae P. aeruginosa A. baumannii S. aureus p value
Surgical site 0 1 (25%) 1 (25%) 2 (50%) NS
Pneumonia 3 (60%) 1 (20%) 1 (20%) 0 NS
Urinary tract 2 (66.6%) 1 (33.4%) 0 0 NS
Primary bloodstream 2 (33.3%) 2 (33.3%) 2 (33.3%) 0 NS
Total 7 5 4 2 NS
NS=not significant.
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Between all variables considered by the risk Index, the
length of surgery is the hazard factor most prone to
discrepancies between institutions [5]. In our study, 65.4% of
the surgery procedures were longer than the NNISS
recommended time, what could be explained by the fact that
the institution is a teaching hospital.
As with any patient, the risk of postoperative infections
increases with the length of vascular access, the length of
orotracheal intubation, the presence of indwelling catheters
and the presence of devitalized tissue or fluid collections [3].
Also, the degree of immunosuppression, the need to additional
anti-rejection therapy, and other infections like
cytomegalovirus and hepatitis C could weaken the host
defenses [14].
The high rate of infection found in this study, especially
surgical site infections, suggests a demand for stricter
prevention measures and control of health care-related
infections in the institution, mostly during the perioperatory
period.
Better detailed epidemiological studies are essential for
evaluating health care-related infections surveillance actions
and prognosis of solid organ transplant submitted patients.
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